share_log

Caribou Biosciences Q1 EPS $(0.46) Misses $(0.40) Estimate, Sales $2.43M Miss $2.90M Estimate

Benzinga ·  May 7 17:16

Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.40) by 15 percent. This is unchanged from the same period last year. The company reported quarterly sales of $2.43 million which missed the analyst consensus estimate of $2.90 million by 16.24 percent. This is a 30.64 percent decrease over sales of $3.50 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment